Quick Takeaways
- TCG Crossover GP II, LLC filed SCHEDULE 13G for Vor Biopharma Inc. Common Stock, par value $0.0001 per share (VOR).
- Disclosed ownership: 10%.
- Date of event: 30 Mar 2026.
TCG Crossover GP II, LLC - 30 Mar 2026 SCHEDULE 13G Report for Vor Biopharma Inc. Common Stock, par value $0.0001 per share (VOR)
- Filing Manager
- TCG Crossover GP II, LLC
- Reporting Manager
- Chen Yu
- Symbol
- VOR
- Shares outstanding
- 54,029,314 shares
- Disclosed Ownership
- 5,673,078 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Apr 2026, 17:29:06 UTC
- Date of event
- 30 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP II, LLC disclosed 10% ownership in Vor Biopharma Inc. Common Stock, par value $0.0001 per share (VOR) on 30 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 01 Apr 2026, 17:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 5.2% | 2,836,539 | 0 | 2,836,539 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund II, L.P. | 5.2% | 2,836,539 | 0 | 2,836,539 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover GP III, LLC | 5.2% | 2,836,539 | 0 | 2,836,539 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| TCG Crossover Fund III, L.P. | 5.2% | 2,836,539 | 0 | 2,836,539 | /s/ Craig Skaling | Craig Skaling, Authorized Signatory | |
| Chen Yu | 10% | 5,673,078 | 0 | 5,673,078 | /s/ Craig Skaling | Craig Skaling, as Attorney-in-Fact for Chen Yu |